BDBM351896 (S)-5-(2-(1H-Imidazo[4,5-b]pyrazin-2-yl)propan-2-yl)-2-(4-tert-butoxyphenyl)-9-fluoro-5H-chromeno[2,3-b]pyridine::US9796720, 11

SMILES CC(C)(C)Oc1ccc(cc1)-c1ccc2[C@H](c3cccc(F)c3Oc2n1)C(C)(C)c1nc2nccnc2[nH]1

InChI Key InChIKey=CHAAKBZKWZRRGK-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 351896   

TargetGlucocorticoid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM351896((S)-5-(2-(1H-Imidazo[4,5-b]pyrazin-2-yl)propan-2-y...)
Affinity DataKi:  0.820nMAssay Description:In order to measure the binding of compounds on the glucocorticoid receptor a commercially available kit was used (Glucocorticoid receptor competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent